Evidence map›Paper›PMID 40606620›Full record

ArticleFrontiers in pharmacology2025

Investigating the underlying mechanisms of the ethanol extract of saussureae involucratae herba in anti-rheumatoid arthritis effect based on sphingolipidomics.

Pingyuan Chi, Hairong Zhang, Yingjie Chen, Jianhua Xie, Yiming Ayixianmuguli, Caisheng Wu, Mingyuan Liu

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pingyuan Chi *School of Pharmaceutical Sciences, Jiamusi University, Jiamusi, China.
Hairong Zhang *Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
Yingjie ChenXiamen Key Laboratory for Clinical Efficacy and Evidence-Based Research of Traditional Chinese Medicine, Xiamen University, Xiamen, China.
Jianhua XieDepartment of Food and Biological Engineering, Zhangzhou Institute of Technology, Zhangzhou, China.
Yiming AyixianmuguliSchool of Medical Sciences, Shihezi University, Shihezi, China.
Caisheng WuFujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
Mingyuan LiuSchool of Pharmaceutical Sciences, Jiamusi University, Jiamusi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Saussureae Involucratae Herba (SIH), a traditional Chinese Medicine, is clinically used in treating rheumatoid arthritis (RA). However, the anti-RA mechanisms of SIH remain unclear. Dysregulation of sphingolipid metabolism is related to the pathogenesis of RA. This study aims to investigate whether the regulation of sphingolipid metabolism is involved in the anti-RA effects of an ethanol extract of SIH (SIE). Methods: The collagen-induced arthritis (CIA) mouse model and LPS-stimulated RAW 264.7 cells were used. Targeted sphingolipidomics were employed to investigate the effects of SIE on the regulation of sphingolipid metabolism in CIA mice. Results: Results showed that SIE significantly reduced arthritis scores and the average thickness of the four paws (both Discussion: We, for the first time, found that SIE has anti-RA effects in CIA mice and that regulation of sphingolipid metabolism is involved in its anti-RA action. These findings provide pharmacological evidence for the use of SIH in managing RA and support the theory that targeting sphingolipid metabolism is a strategy for treating RA.

Indexed as

HPLC-MS/MSrheumatoid arthritisS1P signaling pathwaysaussureae involucratae herbasphingolipidomics

Identifiers

PMID40606620
PMCPMC12213489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.